Image

A New Objective Titration Procedure for the Treatment of Mandibular Advancement Device in OSAHS Patients

Recruiting
18 - 70 years of age
Both
Phase N/A

Powered by AI

Overview

The aim of this clinical trial is to apply a new objective titration procedure in obstructive sleep apnea hypopnea syndrome (OSAHS) patients treated with mandibular advancement device (MAD), and to compare this new objective titration procedure with the subjective titration procedure which is commonly used in clinical practice. The remotely intelligent sleep monitoring system (RISMS) will be used in the new objective titration procedure. The main questions it aims to answer are:

  1. The efficacy of MAD therapy after each titration procedure.
  2. The titration time efficiency and the improvement of subjective symptoms after each titration procedure.

Description

In this study, patients diagnosed with OSAHS and referred for MAD treatment will be recruited. The amount of mandibular protrusion seems to be a key factor in the treatment of MAD. Patients will experience either of the two titration procedures to obtain the optimal mandibular protrusion. One procedure is a new objective titration procedure which will use the RISMS for the treatment of MAD, which will help the clinician instruct the titration according the objective therapeutic indicator. The other procedure is the subjective titration procedure which is commonly used in clinical practice. Finally, the researchers will compare the efficacy of the MAD therapy, the titration time efficiency and the improvement of subjective symptoms between the two titration procedures.

Eligibility

Inclusion Criteria:

  • OSAHS patients with AHI≥15
  • 18≤age≤70 years;
  • Subject is capable of giving informed consent
  • refusal of or noncompliance with CPAP (continuous positive airway pressure) or unwilling to undergo upper airway surgery
  • Normal clinical, periodontal and temporomandibular joint examination

Exclusion Criteria:

  • Active periodontal problems including tooth mobility
  • active temporomandibular joint dysfunction
  • Edentulous patients or Insufficient teeth to support MAD
  • patients with severe unstable systemic diseases or suffering from psychiatric disorders
  • Enlarged palatine tonsils (Friedman grade IV tonsils)

Study details

Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)

NCT06424405

Beijing Jishuitan Hospital

24 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.